Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertension.
Price LC, Kouranos V, Baughman R, Bloom C, Stewart I, Shlobin O, Nathan S, Dimopoulos K, Falconer J, Gupta R, McCabe C, Samaranayake C, Mason T, Mukherjee B, Taube C, Sahni A, Kempny A, Semple T, Renzoni E, Wells A, Wort SJ.
Price LC, et al. Among authors: sahni a.
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Mar 26;41(1):e2024024. doi: 10.36141/svdld.v41i1.15515.
Sarcoidosis Vasc Diffuse Lung Dis. 2024.
PMID: 38567554
Free PMC article.
No abstract available.